---
title: "InflaRx dips 16%, prices $30M stock offering"
date: "2025-02-14 10:15:07"
summary: "InflaRx N.V. (NASDAQ:IFRX) priced its underwritten public offering of 8.25M shares at an offering price of $2.00 per ordinary share, and pre-funded warrants to purchase up to 6.75M shares. All ordinary shares and pre-funded warrants in the offering are being sold by the company. The offering is expected to close..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

InflaRx N.V. (NASDAQ:[IFRX](https://seekingalpha.com/symbol/IFRX "InflaRx N.V.")) [priced](https://seekingalpha.com/pr/20002659-inflarx-announces-pricing-of-30-million-public-offering-of-ordinary-shares-and-pre-funded "priced") its underwritten public offering of 8.25M shares at an offering price of $2.00 per ordinary share, and pre-funded warrants to purchase up to 6.75M shares.

All ordinary shares and pre-funded warrants in the offering are being sold by the company. 

The offering is expected to close on February 18, 2025.

Underwriters have a 30-day option to purchase up to 2.25M additional ordinary shares.

The company intends to use the net proceeds from the offering primarily to fund clinical development of its pipeline candidates, including vilobelimab and INF904, and for general corporate purposes.

The stock price dropped ~16% on Friday during pre-market hours of trading.

[seekalpha](https://seekingalpha.com/news/4408368-inflarx-dips-16-prices-30m-stock-offering)
